| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer | Executive VP, Research +1 more
2 companies
Church Kevin serves as a Chief Scientific Officer at LONA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 7 sells. Those positions are worth an estimated $277K at current prices.
The biggest single holding is ATHA (~$142K) as Chief Scientific Officer. The recent filings there lean toward selling, a net 25,463 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | LONA Leonabio, Inc. | Chief Scientific Officer | Sale+OE | 1,359 | $5.37 | $7,297.83 | -5.1% | +48.1% | - | |
| Jan 2, 2026 | Chief Scientific Officer | Sale+OE | 876 | $6.88 | $6,026.88 | -4.1% | - | - | ||
| Jul 1, 2025 | Chief Scientific Officer | Sale+OE | 8,526 | $0.29 | $2,502.38 | -4.8% | - | - | ||
| Jan 2, 2025 | Chief Scientific Officer | Sale+OE | 8,510 | $0.56 | $4,781.77 | -6.1% | - | - | ||
| Sep 5, 2024 | Chief Scientific Officer | Sell | 2,525 | $0.57 | $1,429.15 | -2.7% | - | - | ||
| Jan 5, 2023 | Chief Scientific Officer | Sell | 2,412 | $2.91 | $7,018.92 | -2.9% | - | - | ||
| Jun 23, 2022 | Executive VP, Research | Sell | 2,614 | $2.69 | $7,031.66 | -4.3% | - | - |